Mistras Group, Inc. (MG) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed
Updated Sep 22, 2026Q2 FY2026 reviewed
Mistras Group provides non-destructive testing and inspection services for industrial assets, including data centers and power plants.
Revenue +4.2% YoY
Fourth consecutive quarter of year-over-year growth.
Infra +76.5% YoY
Data-center and LNG inspection work drives the jump.
Leverage 2.2x
Lowest since 2018; target is 2x by end-2026.
Oil & gas 51%
Still the largest end market; deferrals pushed further out.
The Buildout Takeaway
The mix is shifting underneath a mid-single-digit top line. Infrastructure, power and aerospace work is growing quickly while oil & gas shrinks, and management raised full-year guidance on the back of it. The bind is capacity, not demand — laboratories and qualified technicians gate how fast that work turns into revenue. The open question is whether the growth engines hold while the largest end market keeps deferring work further out.
18 analysts·6 Buy11 Hold1 Sell
Coverage is thin — no price estimates on file, so no target is shown

FY2026 revenue $740–755M · adjusted EBITDA $92–95M · effective tax rate ~25% · leverage target 2x by end-2026 · favorable free cash flow in H2 2026
Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.
Our View

The Verdict

Mistras Group inspects and tests industrial assets for soundness — pipes, pressure vessels, welds, aircraft parts, wind turbines and power-plant equipment. Its non-destructive testing crews and its laboratories verify that critical structures will not fail, and its software turns that inspection data into predictive maintenance. That work now reaches data-center construction and the power infrastructure built to feed it, where customers need quality assurance, inspection, commissioning support and asset-integrity expertise on complex projects. Management describes the data-center job as familiar testing applied to a new use case, not a different business.

Market Cap—
Revenue (TTM)$739M
Revenue Growth+5.2%
EBITDA Margin (TTM)11.9%
Net Debt$178M
Earnings Beats5 of 7
P/E (TTM)—
EV/EBITDA (TTM)—

What We Like

  • The mix shift is real: oil & gas fell from ~60% to ~51% of revenue in a year, while strategic end markets (aerospace & defense, infrastructure, power and industrials) grew 28% in aggregate in Q2 2026.
  • Operating leverage is showing: Q2 operating income rose 53.6% to $12.9M on 4.2% revenue growth. Management says roughly 60% of incremental revenue converts into operating income and calls that sustainable.
  • Guidance was raised at the Q2 2026 call, to $740–755M revenue and $92–95M adjusted EBITDA from $730–750M and $91–93M a quarter earlier.
  • The balance sheet is improving: bank-defined leverage was ~2.2x at June 30, 2026, which management says is the lowest since 2018, against a 3.75x covenant. Free cash flow improved $23.9M versus the prior-year quarter.
  • Capacity is being built: management projects tripling in-lab testing capacity by end-2027, with Houston and Los Angeles lab expansions announced. Customers are reserving capacity and are willing to co-invest in ultrasonic testing equipment.

What We’re Watching

  • Aerospace & defense growth slowed from +35.5% in Q1 2026 to +13.2% in Q2 2026 — the strongest growth engine, decelerating without being remarked upon.
  • PCMS software metrics went silent: Q1 disclosed 11 new logos, 29 expansions and growth 'over 10%' (down from 25.2% for the prior full year); the Q2 call carried no PCMS metric at all.
  • Gross-margin rate expansion narrowed to +10 bps year over year in Q2 2026 from +120 bps in Q1, even as absolute profit rose sharply.
  • Oil & gas deferrals persist — management says the majority of first-half 2026 deferrals 'will continue to be pushed further out' — and oil & gas is still ~51% of revenue.
Bottom Line

The thesis is intact and strengthening on the pieces management controls. Guidance moved from reaffirmed to raised within one quarter, leverage is at its lowest since 2018, free cash flow swung positive, and the revenue mix is rotating toward aerospace, infrastructure and power. It is weakening on the pieces management does not: the largest end market keeps deferring work, aerospace growth more than halved sequentially, and the software metric volunteered in Q1 disappeared in Q2. The open question is whether in-lab capacity converts inside the 9–12 month lead time management cites — that is what separates the promised second-half recovery from a delayed one.

Next upThe next hard data point is Q3 2026 earnings, which tests whether the raised full-year guidance holds and whether oil & gas stabilizes at the 'flat to moderate' growth management expects. It also carries the second-half cash-flow recovery and the path to the 2x leverage target.
Last Quarter — Q2 FY2026

Earnings Beat

Q2 2026 revenue was $193.1M, up 4.2% year over year and the fourth consecutive quarter of growth. Gross margin was 29.2%. Operating income rose 53.6% to $12.9M from $8.4M, and management called the $25.8M of adjusted EBITDA its highest ever for a second quarter, at a 13.3% margin. Free cash flow improved $23.9M versus the prior-year quarter.

MetricQ2 FY2026Q1 FY2026Q2 FY2025YoY
Revenue$193M$169M$185M+4.2%
Gross margin29.2%25.1%27.7%+150bps
EBITDA$21M$13M$20M+8.2%
EPS$0.23$0.07$0.09+144.1%
Bank-defined leverage2.2x2.4xn/a—
Our visibility is not defined by a single backlog metric… it's not a single metric of backlog that defines our visibility.— Natalia Shuman, CEO, 2026-08-11

Management tone: Management moved from reaffirming guidance on the Q1 2026 call to raising it on the Q2 2026 call. On the Q2 call they were direct where they had a comfortable number: confirming the raise came from aerospace and infrastructure strength with oil & gas flat to down, endorsing roughly 60% incremental conversion as 'sustainable, absolutely,' and explaining the $8M 'other revenue' line as diversified small call-out work. They reframed where they did not have one — declining to give segment backlog figures, offering no concrete M&A timeline, and not confirming the in-lab shift milestones, citing 9–12 month lead times instead. Language on oil & gas moved toward more specific and more conservative framing, with deferrals now described as continuing to be pushed out.

Management Guidance

Management raised FY2026 guidance at the Q2 2026 call to revenue of $740–755M, from $730–750M, and adjusted EBITDA of $92–95M, from $91–93M. The stated driver was 'continued strength in our strategic growth markets, particularly offset by a low level of activity in our oil and gas end market attributable to ongoing macro environment factors, including higher crude oil prices.' Management reaffirmed an effective tax rate of about 25%, a 2x leverage target by end-2026 through residual free cash flow debt paydown, and a return to historically favorable cash flow in the second half. It added one new longer-dated commitment: tripling in-lab testing capacity by the end of 2027.

Business Trajectory

Trajectory

Revenue has grown year over year for four consecutive quarters, reaching $193.1M in Q2 2026, up 4.2%. The composition underneath is doing the work: oil & gas fell 8.2% in Q2 after an 11.5% drop in Q1, while aerospace & defense, infrastructure and power grew enough to keep the blended line positive. Management says that after adjusting for 2026 turnarounds and work exited in 2025, oil & gas revenue was up 1% in Q2. Profitability improved in dollars — operating income rose 53.6% — but the rate of gross-margin expansion narrowed to 10 bps year over year in Q2 from 120 bps in Q1. Free cash flow has been uneven on the audited figures: negative $3.2M in Q1 2026 and positive $10.1M in Q2 2026.

Revenue & Margin Trajectory
RevenueGross margin$0$100$200$168M$170M$163M$170M$180M$188M$188M$192M$182M$181M$177M$201M$192M$179M$160M$124M$148M$161M$154M$178M$175M$171M$162M$179M$178M$168M$168M$176M$179M$182M$184M$190M$183M$173M$162M$185M$196M$182M$169M$193M30%29%Q3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
RevenueGross margin$0$100$200$168M$170M$163M$170M$180M$188M$188M$192M$182M$181M$177M$201M$192M$179M$160M$124M$148M$161M$154M$178M$175M$171M$162M$179M$178M$168M$168M$176M$179M$182M$184M$190M$183M$173M$162M$185M$196M$182M$169M$193M30%29%Q3'16Q4Q1'17Q2Q3Q4Q1'18Q2Q3Q4Q1'19Q2Q3Q4Q1'20Q2Q3Q4Q1'21Q2Q3Q4Q1'22Q2Q3Q4Q1'23Q2Q3Q4Q1'24Q2Q3Q4Q1'25Q2Q3Q4Q1'26Q2
Gross margin as reported.
Share Price — 12 Months
$10$20$052-wk high $20Sep '25DecMar '26JunSep '26
52-week range $10–$20.
Share Price — 12 Months
$10$20$052-wk high $20Sep '25DecMar '26JunSep '26
52-week range $10–$20.
The Numbers

The Model

The model projects FY+1 revenue of $752M with EBITDA of $86M, an 11.5% margin, then FY+2 revenue of $805.0M with EBITDA of $101M, a 12.5% margin. Near term, the anchor is the mix already in motion — strategic end markets growing while oil & gas stabilizes — plus the capacity already added. The margin dips to 11.5% in FY+1 before expanding to 12.5% in FY+2, which is where the in-lab expansion converting into revenue and operating leverage on that fixed cost base would show up.

Revenue & EBITDA Projections
REVENUE$724M$752M$805MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$84M$86M$101M12.5%FY25FY+1 (E)FY+2 (E)
REVENUE$724M$752M$805MFY25FY+1 (E)FY+2 (E)EBITDA & MARGIN$84M$86M$101M12.5%FY25FY+1 (E)FY+2 (E)
Solid bars are reported actuals; outlined bars are model projections — not company guidance.
MetricFY2025Next FY (E)Following FY (E)
Revenue$724M$752M$805M
YoY Growth—+3.9%+7.0%
EBITDA$84M$86M$101M
EBITDA Margin11.5%11.5%12.5%

Projections are the median of 5 independent model runs. The model’s revenue sits 2.4% above analyst consensus.

Management raised FY2026 guidance at the Q2 2026 call to revenue of $740–755M, from $730–750M, and adjusted EBITDA of $92–95M, from $91–93M. The stated driver was 'continued strength in our strategic growth markets, particularly offset by a low level of activity in our oil and gas end market attributable to ongoing macro environment factors, including higher crude oil prices.' Management reaffirmed an effective tax rate of about 25%, a 2x leverage target by end-2026 through residual free cash flow debt paydown, and a return to historically favorable cash flow in the second half. It added one new longer-dated commitment: tripling in-lab testing capacity by the end of 2027.

What Could Go Right — and Wrong

What good looks like
  • Oil & gas stabilizes at the 'flat to moderate' growth management expects. It is still ~51% of revenue, so a turn there swings the blended growth rate more than any other line.
  • New in-lab capacity comes online inside the 9–12 month lead time, letting aerospace & defense revenue re-accelerate into the capacity being built.
  • PCMS and the data business resume double-digit growth and management restarts disclosing logo and expansion counts.
  • Data-center and power work — estimated at about 15% of Q2 2026 revenue for infrastructure and power combined, and not separately disclosed — grows enough to be quantified as a named line.
  • Second-half free cash flow lands as promised and debt paydown reaches the 2x leverage target, leaving more balance-sheet room for the Vision 2030 plan.
What could go wrong
  • Oil & gas deferrals keep being pushed out, and the largest end market at ~51% of revenue keeps dragging on the blended growth rate.
  • Aerospace & defense growth keeps sliding from +35.5% in Q1 2026 toward +13.2% in Q2 2026 faster than the capacity expansion converts.
  • The tight market for qualified technicians and supplier capacity keeps gating revenue conversion and pressures margin if wage costs outrun pricing discipline.
  • Gross-margin rate expansion keeps narrowing — +120 bps in Q1 2026 to +10 bps in Q2 2026 — if the incremental-conversion benefit is a capacity honeymoon rather than a permanent operating fact.
  • Competitive intensity in the best markets: the 10-K names TIC Solutions, SGS Group, the Team IHT Segment and APPLUS RTD as non-destructive testing services competitors, and Element Materials Technology in in-house laboratory testing, particularly within aerospace and defense.
What’s Next

Looking Ahead

Over the next twelve months the story turns on conversion rather than demand. Management has promised a return to historically favorable free cash flow in the second half of 2026 and deleveraging to a 2x target by year-end, while projecting in-lab capacity tripling by the end of 2027 on a 9–12 month investment-to-revenue lead time. Alongside that, the company has opened several new U.S. field-services locations, announced Houston and Los Angeles lab expansions, hired an Executive Director of AI to form an AI center of excellence, and launched AEScout. Each of these is a claim to be tested against revenue in the coming prints rather than a result already in the numbers.

Catalysts
  • Summertime 2026Hub shift milestones — Third hub to three shifts, fourth possible by year-end; not re-confirmed.
  • H2 2026Cash flow recovery — Target is a return to historically favorable free cash flow.
  • Q3 2026Q3 earnings report — Next hard data point; tests whether the raised guidance holds.
  • End of 20262x leverage target — Residual free cash flow applied to pay down debt.
  • End of 2027Triple in-lab capacity — Management projects tripling in-lab testing capacity.
Numbers

Financials

Annual Summary

MetricFY2024FY2025TTMYoY
Revenue$730M$724M$739M-0.8%
Gross Margin27.9%26.7%27.5%125bps
EBITDA$73M$84M$88M+14.9%
EBITDA Margin10.0%11.5%11.9%+157bps
Net Income$19M$17M$27M-11.6%
Free Cash Flow$27M$5M$27M—
Net Cash————

Key Ratios (Trailing)

Valuation
  • P/E TTM—
  • EV/EBITDA TTM—
  • EV/Revenue TTM—
  • Price/FCF TTM—
Profitability
  • Gross Margin (TTM)27.5%
  • EBITDA Margin (TTM)11.9%
  • Net Margin (TTM)3.7%
  • ROIC10.5%
  • FCF Conversion30.3%
  • SBC / Revenue1.0%
Reference

The Company

Mistras Group is an industrial inspection and testing company. Its crews go onto industrial sites and its laboratories test materials to verify that critical structures and components are sound — pipes, pressure vessels, welds, aircraft parts, wind turbines and power-plant equipment that cannot be allowed to fail. It works through non-destructive testing methods including ultrasonic testing, visual inspection, magnetic particle testing and radiography, plus in-laboratory materials testing and software that turns inspection data into predictive maintenance. The 10-K describes it as 'a global leader in technology-enabled industrial asset integrity and laboratory testing solutions,' serving oil & gas, aerospace & defense, power & utilities, manufacturing and civil infrastructure.

MG reports three segments — North America, International, and Products and Systems — and operates from Princeton Junction, New Jersey, which it describes as its primary location and where most of its manufacturing and research and development is conducted. It owns properties in Monroe, North Carolina; Trainer, Pennsylvania; LaPorte, Texas; Burlington, Washington; Evanston, Wyoming; and Jonquiere, Quebec, Canada, and designs and manufactures automated ultrasonic systems and scanners in France. Revenue is reported in two types, Integrated Field Solutions and In-Laboratory Services, the latter absorbing the Data Analytical Solutions line in Q1 2026 — a change that removed standalone visibility into the data business.

Business Segments

North America
$135.3M in Q1 2026 revenue
NDT, inspection, in-lab testing and engineering services for energy, industrial and commercial aerospace components.
Growth driver: In-lab aerospace & defense capacity expansion
International
$36.3M in Q1 2026 revenue
Services, products and systems for select markets in Europe, the Middle East, Africa, Asia and South America.
Growth driver: Recent growth predominantly FX, not organic
Products and Systems
$2.65M in Q1 2026 revenue
Designs, manufactures, sells, installs and services asset protection monitoring products and instrumentation, predominantly in the United States.
Growth driver: Revenue fell 14.2% in Q1 on lower shipments

Competitive Landscape

The 10-K names MG's competitors directly: TIC Solutions, SGS Group, the Team IHT Segment and APPLUS RTD in non-destructive testing services; Element Materials Technology in in-house laboratory testing, particularly within aerospace and defense; and UltraPIPE, Lloyd's Register Capstone, Inc. and Meridium Systems in asset integrity management software. The filing returns no sole-source disclosures, so there is no evidence MG is a single-source supplier of anything. What the record describes as its advantage is scale, technical capability, embedded customer programs and proprietary software — not an irreplaceable product. A computed criticality assessment reaches the same point from the other direction: were MG to disappear, the data-center buildout would not slow materially, because inspection work could shift to competing providers. The competitive caution in the material comes from a neighbor read-through: TIC is larger, cross-sells inspection into data centers, LNG and bridges, landed a $30M multiyear LNG master services agreement, and reports a record combined backlog of $1.18B, up 20% year over year.

  • TIC Solutions
    Named in the 10-K as an NDT services competitor. Its own disclosures show inspection and mitigation revenue of -5.5% year over year, but +4% excluding site losses and outage shifts, a $30M multiyear LNG agreement, and record combined backlog of $1.18B, up 20%.
  • SGS Group
    Named in filings; not discussed.
  • Team IHT Segment
    Named in filings; not discussed.
  • APPLUS RTD
    Named in filings; not discussed.
  • Element Materials Technology
    Named in filings as a competitor in in-house laboratory testing, particularly within the aerospace and defense end market; not otherwise discussed.
All competitor names come from the 10-K's own disclosure; only TIC Solutions carries additional detail, and that comes from a neighbor read-through of TIC's own results, not from MG.

Supply Chain

MG sits between the industrial and energy customers it inspects for and the labor, equipment and materials its crews need. The 10-K discloses no sole-source relationships, and no supplier or customer in the supplied material names MG by name.

Analysis updated Sep 22, 2026, reviewing Q2 FY2026. Prices delayed. Built with The Buildout’s published methodology. Not investment advice. No positions held. © The Buildout 2026.

More on MG: Earnings recap